U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C16H23NO4
Molecular Weight 293.3581
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROMOLATE

SMILES

CC(C)(OC1=CC=CC=C1)C(=O)OCCN2CCOCC2

InChI

InChIKey=GMISKEUWHIRDNK-UHFFFAOYSA-N
InChI=1S/C16H23NO4/c1-16(2,21-14-6-4-3-5-7-14)15(18)20-13-10-17-8-11-19-12-9-17/h3-7H,8-13H2,1-2H3

HIDE SMILES / InChI

Description

Promolate is an Isobutyric acid derivative with potent antitussive activity. In preclinical studies, Promolate shows low toxicity in experimental animals and an antitussive action like that of codeine, but without the side effects of the latter. Promolate displayed a dose-dependent antitussive effect in conscious guinea pigs with coughing induced by NH3 aerosol. The activity of Promolate did not diminish when it was administered orally to guinea pigs for 20 days. Promolate also displayed a dose-dependent antitussive effect in Na barbital anesthetized cats with coughing induced by stimulation of the superior laryngeal nerve. High doses of Promolate administered to rats for 125 days did not provoke side effects.

Originator

Approval Year

PubMed

Sample Use Guides

In Vivo Use Guide
guinea pig: 400-​1400 mg​/kg orally or rectally
Route of Administration: Oral